SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,123.83 -125.56
( -0.17%)

Global Indices

Nasdaq

52,230.09 -658.89
(-1.25%)

Dow Jones

7,644.13 -40.30
(-0.52%)

Hang Seng

62,584.98 -322.86
(-0.51%)

Nikkei 225

10,670.63 -54.40
(-0.51%)

Forex

USD-INR

94.51 -0.31
(-0.33%)

EUR-INR

106.10 -0.35
(-0.33%)

GBP-INR

126.51 -0.13
(-0.10%)

JPY-INR

0.60 0.00
(-0.28%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

276.4035981

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

43.02

1037.7

EPS(TTM)

Face Value()

Div & Yield %

20.47

0.06

Back

cummins india ltd

Advanced Enzyme Technologies consolidated net profit declines 7.11% in the June 2026 quarter

Aug 08,2026

Net profit of Advanced Enzyme Technologies declined 7.11% to Rs 37.09 crore in the quarter ended June 2026 as against Rs 39.93 crore during the previous quarter ended June 2025. Sales rose 2.09% to Rs 189.79 crore in the quarter ended June 2026 as against Rs 185.91 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	189.79	185.91	2
OPM %	26.86	30.35	-
PBDT	63.41	64.52	-2
PBT	53.53	54.90	-2
NP	37.09	39.93	-7

73,123.83 -125.56 ( -0.17%)

52,230.09 -658.89 (-1.25%)

7,644.13 -40.30 (-0.52%)

62,584.98 -322.86 (-0.51%)

10,670.63 -54.40 (-0.51%)

94.51 -0.31 (-0.33%)

106.10 -0.35 (-0.33%)

126.51 -0.13 (-0.10%)

0.60 0.00 (-0.28%)